JOSD1 Human

Josephin Domain Containing 1 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Protein Structure and Catalytic Activity

JOSD1 is a 202-amino-acid protein (UniProt accession: Q15040) with an N-terminal Josephin domain responsible for deubiquitination. Key features include:

  • Substrate Specificity: Cleaves K48- and K63-linked polyubiquitin chains in vitro .

  • Localization: Primarily cytoplasmic and nuclear, with membrane-targeting capabilities .

  • Post-Translational Regulation: Activated by ubiquitination, enhancing its enzymatic activity .

PropertyDescriptionSource
Molecular Weight~23 kDa (predicted)
Recombinant FormN-terminal His-tagged, affinity-purified from E. coli (≥90% purity)
Catalytic ActivityDUB activity confirmed against monoubiquitin and polyubiquitin chains

Regulation of Signaling Pathways

JOSD1 modulates key signaling cascades through deubiquitination:

Hippo/YAP Pathway

  • Mechanism: Stabilizes YAP by deubiquitinating and preventing its degradation.

  • Cancer Impact: Promotes proliferation and migration in colon cancer (HCT116, SW480 cells) . Knockdown reduces tumor growth in xenograft models.

Snail-Mediated Epithelial-to-Mesenchymal Transition (EMT)

  • Mechanism: Deubiquitinates Snail, enhancing its stability and EMT in lung adenocarcinoma (LUAD) .

  • Clinical Correlation: High JOSD1 levels in LUAD correlate with poor prognosis (OS: P = 0.02) .

Proteotoxic Stress Response

  • Role: Mitigates hepatic proteotoxicity by stabilizing misfolded proteins and reducing apoptosis .

Interaction Network and Functional Partners

JOSD1 interacts with proteins involved in ubiquitination, proteostasis, and signaling:

Interacting ProteinFunctionInteraction ScoreSource
ATXN3DUB involved in protein quality control and transcriptional regulation0.954
UBCPolyubiquitin-C precursor; substrate for JOSD1’s catalytic activity0.913
USP15DUB regulating TGF-β signaling and NF-κB pathways0.667

Key Insights:

  • ATXN3: Shares structural and functional similarities with JOSD1, suggesting conserved roles in protein homeostasis .

  • UBC: Provides ubiquitin chains for JOSD1’s enzymatic processing, critical for substrate specificity .

Oncogenic Roles and Prognostic Impact

JOSD1 overexpression is linked to aggressive cancer phenotypes:

Cancer TypeMechanismClinical CorrelationSource
Colon CancerYAP stabilization → Enhanced proliferation/migrationPoor survival (HCT116, SW480)
Lung Adenocarcinoma (LUAD)Snail stabilization → EMT/metastasisHigh JOSD1 → Poor OS/DSS
Gynecological CancerMCL1 stabilization → ChemoresistanceApoptosis evasion

Experimental Validation:

  • Knockdown Studies: Reduced tumor growth (LUAD xenografts: 1.60 ± 0.28 vs. 0.56 ± 0.12 g, P < 0.001) .

  • Migration Assays: Wound healing assays showed impaired migration in JOSD1-silenced colon cancer cells .

In Vitro and In Vivo Studies

ModelObservationMechanismSource
HCT116 (Colon Cancer)JOSD1 knockdown ↑ cleaved caspase-3 → ApoptosisYAP degradation
A549 (LUAD)JOSD1 knockdown ↓ metastasisSnail destabilization
Hepatic Stress ModelJOSD1 overexpression ↓ proteotoxicityMisfolded protein stabilization

Key Data:

  • EdU Proliferation Assay: JOSD1 knockdown reduced proliferating cells in LUAD (EdU+ cells: 79.8% → 34.2%, P < 0.001) .

  • Transwell Invasion: JOSD1 depletion ↓ invasion capacity in colon cancer cells .

Targeting JOSD1 in Cancer

  • Strategies: Inhibiting JOSD1 to destabilize pro-survival proteins (e.g., YAP, Snail, MCL1).

  • Challenges: Off-target effects due to its broad role in proteostasis .

Product Specs

Introduction
Josephin-1 (JOSD1) exhibits minimal protease activity towards poly-ubiquitin chains in laboratory settings. It acts as a deubiquitinating enzyme. The ubiquitin-binding sites within the Josephin domain contribute to the binding and cleavage of ubiquitin chains.
Description
Recombinant JOSD1 Human, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 225 amino acids (specifically, amino acids 1 to 202). It has a molecular weight of 25.6 kDa. A 23 amino acid His-tag is fused to the N-terminus of JOSD1. Purification is achieved using proprietary chromatographic methods.
Physical Appearance
A clear, sterile-filtered solution.
Formulation
The JOSD1 protein solution has a concentration of 0.5 mg/ml. It is prepared in a buffer containing 20 mM Tris-HCl (pH 8.0), 0.2 M NaCl, 40% glycerol, 5 mM DTT, and 2 mM EDTA.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freeze the product at -20°C. The addition of a carrier protein like 0.1% HSA or BSA is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
Purity exceeds 90.0%, as determined by SDS-PAGE analysis.
Synonyms
Josephin-1, Josephin domain-containing 1, JOSD1, JSPH1, KIAA0063, dJ508I15.2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSCVPWK GDKAKSESLE LPQAAPPQIY HEKQRRELCA LHALNNVFQD SNAFTRDTLQ EIFQRLSPNT MVTPHKKSML GNGNYDVNVI MAALQTKGYE AVWWDKRRDV GVIALTNVMG FIMNLPSSLC WGPLKLPLKR QHWICVREVG GAYYNLDSKL KMPEWIGGES ELRKFLKHHL RGKNCELLLV VPEEVEAHQS WRTDV.

Q&A

What is JOSD1 and what is its primary function in human cellular systems?

JOSD1 is a member of the deubiquitinating enzyme (DUB) family that belongs to the MJD (Machado-Joseph Disease protein domain) class. Its primary function involves hydrolysis of ubiquitin linkages, participating in protein quality control mechanisms. Unlike some other well-characterized DUBs, JOSD1 demonstrates unique substrate specificities, particularly showing activity toward non-canonical ubiquitination sites. Experimental evidence indicates that JOSD1 can cleave ester-linked model substrates, suggesting its role in regulating non-lysine ubiquitination with efficiency comparable to that of canonical isopeptidases .

How does JOSD1 differ from other deubiquitinating enzymes in the OTU family?

JOSD1 demonstrates a distinct substrate preference profile compared to OTU family DUBs. While many OTU DUBs preferentially cleave lysine-linked ubiquitin substrates (Ub-Lys), JOSD1 has shown significant activity toward threonine-linked ubiquitin substrates (Ub-Thr). When examining cleavage percentages as a function of time between Ub-Lys versus Ub-Thr substrates, JOSD1 demonstrates complementary activity profiles to certain OTU DUBs, suggesting evolutionary specialization for different types of ubiquitin linkages . This distinction positions JOSD1 as a potentially valuable research tool for investigating non-lysine substrate ubiquitination.

What experimental models are most suitable for basic JOSD1 research?

For basic JOSD1 research, both cell-free biochemical assays and cellular models can be employed. For biochemical characterization, purified recombinant JOSD1 protein can be tested against model substrates such as Ub-Lys and Ub-Thr to determine its enzymatic parameters. Activity can be quantified through substrate/product ratio analysis, where the ion intensity signals of substrate and product (ubiquitin) are compared and extrapolated to standard curves .

For cellular models, human cell lines with endogenous JOSD1 expression or those engineered to overexpress or lack JOSD1 can be utilized. When designing experiments for JOSD1 research, it is important to formulate clear research questions and testable hypotheses, following the scientific inquiry process that includes specific experimental procedures and appropriate controls .

How should I design experimental controls when studying JOSD1 substrate specificity?

When investigating JOSD1 substrate specificity, effective experimental controls are essential. A comprehensive experimental design should include:

Positive controls:

  • Known substrates of JOSD1 (Ub-Thr as indicated in search results)

  • Well-characterized DUBs with known activity profiles for comparison

Negative controls:

  • Catalytically inactive JOSD1 mutants (e.g., active site cysteine mutants)

  • Substrate analogs resistant to deubiquitination

Comparative controls:

  • OTU family DUBs (OTU1, OTUD6A, OTUD6B) that show distinct substrate preferences

  • Other MJD family members to identify family-specific versus JOSD1-specific activities

Quantification should involve normalization using the ratio of substrate to product signal intensities, which can be extrapolated to standard curves constructed from defined substrate/product ratios. This approach enables calculation of percentage substrate cleavage and allows direct comparison of JOSD1 activity toward different substrates . The experimental procedure should be repeatable and clearly documented to ensure scientific rigor and reproducibility .

What are the key considerations for formulating research questions and hypotheses in JOSD1 studies?

When formulating research questions and hypotheses for JOSD1 studies, researchers should adhere to established principles of strong scientific inquiry:

  • Research question formulation:

    • Questions should be clear, specific, researchable, and focused

    • Questions must arise from understanding of existing knowledge and identified gaps

    • Questions should be feasible given available time, resources, and methodological tools

  • Hypothesis development:

    • Frame hypotheses in an "If...then...because..." format

    • Ensure hypotheses are testable through empirical methods

    • Connect hypotheses to existing theoretical frameworks about DUB function

  • JOSD1-specific considerations:

    • Focus on unique substrate preferences (e.g., "If JOSD1 preferentially cleaves non-lysine ubiquitin linkages, then mutation of its catalytic domain will affect this specificity because...")

    • Address physiological relevance (e.g., "If JOSD1 regulates non-lysine ubiquitination in vivo, then its depletion will lead to accumulation of specific ubiquitinated substrates because...")

    • Consider contextual factors (cell type, stress conditions, etc.) that might influence JOSD1 activity

This structured approach ensures that JOSD1 research is guided by clear, answerable questions that advance understanding of its biochemical and physiological roles .

What methodological approaches are most effective for measuring JOSD1 activity in complex biological samples?

For measuring JOSD1 activity in complex biological samples, several complementary methodological approaches can be employed:

Biochemical activity assays:

  • Fluorogenic substrates: Utilize Ub-AMC or specifically designed threonine-linked ubiquitin substrates with fluorescent reporters

  • Gel-based assays: Monitor substrate cleavage through SDS-PAGE followed by western blotting

  • Mass spectrometry: Quantify substrate-to-product conversion ratios with high sensitivity

Cellular assays:

  • Pulse-chase experiments to track ubiquitin removal from specific substrates

  • Proximity-based labeling to identify JOSD1-interacting proteins

  • Immunoprecipitation followed by ubiquitin chain analysis

Data analysis considerations:

  • Calculate enzyme kinetic parameters (kcat, KM) for different substrates

  • Use standard curves for quantification and normalization

  • Compare activity under different physiological conditions

When working with human biological samples, ethical considerations must be integrated into the experimental design. This includes obtaining proper informed consent, maintaining confidentiality, and ensuring that the research benefits participating communities . Additionally, researchers should document their experimental procedures in detail to enable reproducibility and consider how their findings might be shared with scientific and broader communities .

How can contradictory data about JOSD1 substrate specificity be reconciled in research?

When facing contradictory data regarding JOSD1 substrate specificity, researchers should implement a systematic approach to reconciliation:

  • Methodological differences assessment:

    • Compare experimental conditions across studies (buffer composition, pH, temperature, enzyme concentrations)

    • Evaluate substrate preparation methods and purity

    • Assess detection techniques and their sensitivity thresholds

  • Biological context considerations:

    • Determine if contradictions arise from different cellular contexts or tissue types

    • Consider post-translational modifications of JOSD1 that might affect activity

    • Evaluate the presence of cofactors or binding partners that could modify specificity

  • Reconciliation strategies:

    • Design experiments that directly compare conditions from contradictory studies

    • Develop more physiologically relevant assays that might resolve apparent contradictions

    • Consider that JOSD1 might have context-dependent substrate preferences

When addressing contradictions, maintain scientific integrity by treating all data with respect and not dismissing findings simply because they contradict expectations. As noted in research on human dimensions, being "honest with yourself" and "not afraid to say you don't know" are key principles for successful scientific inquiry . Document your methodology thoroughly to enable others to reproduce your findings and potentially resolve contradictions.

What are the most significant challenges in translating in vitro JOSD1 findings to in vivo human systems?

Translating in vitro JOSD1 findings to in vivo human systems presents several significant challenges:

  • Physiological complexity factors:

    • Substrate availability and concentration in physiological contexts may differ from in vitro conditions

    • Presence of competing DUBs with overlapping specificities in cellular environments

    • Subcellular localization and compartmentalization affecting enzyme-substrate interactions

  • Methodological limitations:

    • Difficulty in specifically monitoring JOSD1 activity among other DUBs in complex samples

    • Challenges in developing specific inhibitors or activity probes for JOSD1

    • Potential artifacts introduced by overexpression or knockout approaches

  • Translation strategies:

    • Development of cell-type specific and inducible JOSD1 models

    • Use of proximity labeling approaches to identify physiological substrates

    • Employment of patient-derived samples to establish disease relevance

When conducting human-focused research, it's essential to recognize that successful translation requires attending to both technical aspects and human dimensions. Building lasting relationships with clinical collaborators, working with passion and resilience through technical challenges, and practicing effective leadership are all critical components for translational success . Additionally, researchers must ensure ethical integrity when working with human samples by maintaining transparency about how data will be used and ensuring participating communities benefit from the research .

How can advanced computational approaches enhance JOSD1 structure-function analysis?

Advanced computational approaches offer powerful tools for enhancing JOSD1 structure-function analysis:

  • Structural bioinformatics:

    • Homology modeling based on related MJD family proteins

    • Molecular dynamics simulations to understand catalytic pocket flexibility

    • Virtual screening to identify potential inhibitors or activity modulators

  • Systems biology approaches:

    • Network analysis to position JOSD1 within the ubiquitin-proteasome system

    • Integration of proteomics and transcriptomics data to identify condition-specific JOSD1 regulation

    • Pathway enrichment analysis to understand biological processes affected by JOSD1

  • Machine learning applications:

    • Prediction of substrate recognition motifs from known JOSD1 targets

    • Classification of ubiquitination sites most likely to be regulated by JOSD1

    • Integration of multi-omics data to predict cellular consequences of JOSD1 modulation

When implementing computational approaches, researchers should maintain scientific rigor by validating in silico predictions with experimental evidence. As with all research approaches, clearly documenting methods, software versions, and parameters is essential for reproducibility . The integration of computational and experimental approaches represents a powerful strategy for advancing understanding of JOSD1 structure-function relationships.

What ethical frameworks should guide JOSD1 research involving human subjects or tissues?

JOSD1 research involving human subjects or tissues must adhere to robust ethical frameworks:

  • Foundational ethical principles:

    • Respect for persons: Recognizing participant autonomy and protecting those with diminished autonomy

    • Beneficence: Maximizing benefits while minimizing harm

    • Justice: Ensuring fair distribution of research benefits and burdens

  • Practical implementation:

    • Obtaining truly informed consent, with clear explanation of how samples will be used

    • Maintaining confidentiality and privacy of genetic and personal information

    • Engaging with communities whose members contribute to research

    • Establishing transparent protocols for sample storage, use, and potential future applications

  • JOSD1-specific considerations:

    • Clear communication about the research goals and potential implications

    • Addressing potential findings related to disease associations

    • Ensuring that participating communities benefit from any discoveries

Trust is vital at every stage of human subject research, from recruitment and informed consent to confidentiality and protocol compliance. Researchers must go beyond simply following regulations to establish mutual understanding with participants and communities . Public and community engagement through focus groups, meetings with community organizations, and transparent communication can help build this trust and ensure ethical integrity in JOSD1 human research.

How should researchers approach potential JOSD1 biomarker development in human disease contexts?

When approaching JOSD1 biomarker development in human disease contexts, researchers should consider:

  • Biomarker qualification process:

    • Clearly define the intended clinical use (diagnostic, prognostic, predictive)

    • Establish analytical validity through rigorous assay development

    • Demonstrate clinical validity through association with disease states

    • Evaluate clinical utility by showing impact on patient outcomes

  • Methodological considerations:

    • Develop standardized assays for measuring JOSD1 protein levels or activity

    • Ensure appropriate sample handling protocols to preserve enzyme activity

    • Include diverse population samples to address potential demographic variations

  • Ethical and practical implementation:

    • Engage with patient communities to understand priorities and concerns

    • Establish clear protocols for returning results to participants when appropriate

    • Consider how findings might impact participants psychologically and socially

When conducting biomarker research, it's essential to "treat everyone with respect" and "stay humble" . Researchers must remember that trust defines relationships among subjects, investigators, research institutions, and communities . The development of JOSD1 as a biomarker should benefit the participating communities and involve them in meaningful dialogue about how their data will be used.

What approaches can integrate basic JOSD1 enzymatic research with clinical observations?

Integrating basic JOSD1 enzymatic research with clinical observations requires multidisciplinary approaches:

  • Translational research strategies:

    • Correlate JOSD1 activity or expression with clinical phenotypes

    • Analyze patient-derived samples for alterations in JOSD1 function or regulation

    • Develop disease-relevant cellular models that recapitulate clinical observations

  • Collaborative frameworks:

    • Establish partnerships between basic scientists and clinicians

    • Create biorepositories with well-characterized clinical samples and data

    • Implement shared protocols for sample processing and analysis

  • Integration methods:

    • Use multi-omics approaches to connect molecular mechanisms to clinical manifestations

    • Develop physiologically relevant assays that reflect disease conditions

    • Create feedback loops where clinical observations inform basic research questions

The human dimension is critical for successful integration. Building lasting relationships between basic and clinical researchers, working with passion and resilience, and practicing effective leadership are essential . Additionally, ensuring that research benefits participating communities and maintaining transparency about data usage builds the trust necessary for productive collaboration . By embracing both technical expertise and interpersonal skills, researchers can effectively bridge the gap between basic JOSD1 enzymatic research and clinical applications.

What emerging technologies show promise for advancing JOSD1 functional studies?

Several emerging technologies show particular promise for advancing JOSD1 functional studies:

  • Advanced genetic engineering:

    • CRISPR-Cas9 base editing for precise modification of JOSD1 catalytic sites

    • CRISPR interference/activation for temporal control of JOSD1 expression

    • Knock-in of tagged JOSD1 at endogenous loci for physiological expression levels

  • Innovative biochemical approaches:

    • Activity-based probes specific for JOSD1 to monitor enzyme activity in complex samples

    • Proximity labeling techniques to identify physiological JOSD1 substrates and interactors

    • Single-molecule enzymology to understand JOSD1 catalytic mechanisms

  • Imaging technologies:

    • Super-resolution microscopy to visualize JOSD1 subcellular localization

    • Live-cell imaging with fluorescent activity reporters

    • Correlative light and electron microscopy to connect JOSD1 to ultrastructural features

When implementing these technologies, researchers should maintain scientific rigor by clearly documenting their experimental procedures and ensuring reproducibility . The integration of multiple technological approaches can provide complementary insights into JOSD1 function, creating a more comprehensive understanding of this enzyme's biological roles.

How might JOSD1 research contribute to understanding broader ubiquitin biology in human health?

JOSD1 research has significant potential to advance understanding of broader ubiquitin biology in human health:

  • Expanding ubiquitination paradigms:

    • Further characterization of non-lysine ubiquitination, which JOSD1 appears to regulate

    • Understanding the biological significance of diverse ubiquitin linkage types

    • Elucidating how substrate specificity is determined among DUB family members

  • Connections to cellular processes:

    • Investigating JOSD1's role in protein quality control mechanisms

    • Exploring potential functions in cellular stress responses

    • Examining contributions to cell cycle regulation or cell death pathways

  • Disease relevance:

    • Identifying potential roles in neurodegenerative diseases, given the MJD family connection

    • Exploring contributions to cancer biology through regulation of key signaling proteins

    • Investigating metabolic regulation through control of enzyme stability or activity

JOSD1 research exemplifies how understanding specific components of complex biological systems can illuminate broader principles. By investigating this enzyme with complementary approaches—biochemical, cellular, computational, and clinical—researchers can connect molecular mechanisms to human health implications. As with all scientific endeavors, maintaining passion, resilience, and authentic communication will be essential for success .

Product Science Overview

Introduction

Josephin Domain Containing 1 (JOSD1) is a protein encoded by the JOSD1 gene in humans. This protein is characterized by the presence of a Josephin domain, a type of cysteine protease domain that plays a crucial role in the deubiquitination process. Deubiquitination is the removal of ubiquitin from proteins, a process essential for various cellular functions, including protein degradation, signal transduction, and cell cycle regulation .

Structure and Function

JOSD1 is a protein coding gene that produces a polypeptide chain containing 225 amino acids with a molecular mass of approximately 25.6 kDa . The protein is often produced in recombinant form with an N-terminal His-tag to facilitate purification and study. The Josephin domain within JOSD1 is responsible for its deubiquitinase activity, which allows it to cleave ubiquitin from other proteins .

Biological Significance

JOSD1 has been implicated in various cellular processes. It is known to deubiquitinate monoubiquitinated probes in vitro and cleave both ‘Lys-63’-linked and ‘Lys-48’-linked poly-ubiquitin chains . This activity suggests that JOSD1 may play a role in regulating protein stability and function. Additionally, JOSD1 has been shown to increase macropinocytosis and suppress clathrin- and caveolae-mediated endocytosis, thereby enhancing membrane dynamics and cell motility independently of its catalytic activity .

Clinical Relevance

Mutations or dysregulation of JOSD1 have been associated with various diseases, including diabetic retinopathy and microvascular complications of diabetes . The protein’s role in deubiquitination and cellular dynamics makes it a potential target for therapeutic interventions in these conditions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.